Dr. Axel Gille reports

AURORA EXPANDS MEDICAL CANNABIS PORTFOLIO IN GERMANY: NEW FLOWER VARIETIES FOR PATIENTS WITH HIGH THC NEEDS

Aurora Cannabis Inc. has expanded its portfolio in Germany with the launch of two new cannabis flower products for patients. Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA are dried cannabis flower with high tetrahydrocannabinol (THC) content. With these new therapeutic options now available, the company will better meet the individual medical needs of its patients.

"The addition of these two high-THC products to our German portfolio gives physicians even more options to provide patients individually tailored treatments," says Dr. Axel Gille, president of Aurora Europe. "We are committed to bringing high-quality, consistent and innovative cannabis products to our patients in Germany and throughout Europe."

Providing patients with a broad spectrum of cannabis products and formats is important to individualized and patient-specific care. With this portfolio expansion, Aurora solidifies its international market-leading position in medical cannabis.

Pedanios 27/1 FRG CA is medical cannabis flower from the Farm Gas cultivar, with a THC content of about 27 per cent and a cannabidiol (CBD) content of less than 1 per cent. This cultivar is known for its complex aromas and fruity undertones.

Pedanios 29/1 SRD CA is medical cannabis flower from the Sourdough cultivar, with approximately 29 per cent THC and less than 1 per cent CBD. Both Farm Gas and Sourdough are proprietary cultivars developed by Aurora's leading science and innovation business, Occo. They are grown to the highest-quality standards under EU GMP (European Union good manufacturing practice) certified conditions, hang-dried, hand finished and hand bottled, resulting in an exceptional product.

In addition, the company announced it has filed a final short form base shelf prospectus with securities regulators in each of the provinces of Canada, except Quebec, and a corresponding shelf registration statement on Form F-10 with the United States Securities and Exchange Commission.

We seek Safe Harbor.